Moreover, NFκB signaling was activated primarily by stimuli including IL1 signaling, contributing to the development of skin problems in Sharpincpdm mice, and NFκB inhibitor, bortezomib, showed better therapy effect for dermatitis and mouse survival. This evidence concerns the gene NFKB1 and skin disorder.